Daniel J. Brennan, Director of Madrigal Pharmaceuticals MDGL, has filed 0 purchases and 11 sales on the open market. The latest trade was on 06/17.

DB

DB

Daniel J. Brennan

Director

Company

Madrigal Pharmaceuticals MDGL

First filing

23/01/03

Trades

112 trades

Buys / sales

0 / 11

12-month net buying

No record

Last trade

06/17

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Boston ScientificBSX	Open-market sale10b5-1 plan	25/02/18–25/02/19	25/02/19	84,863 sh3 trades	$105.10avg.	$8,919,279.02	−27.3%
Boston ScientificBSX	Open-market sale10b5-1 plan	25/02/12	25/02/13	15,087 sh	$105.07	$1,585,191.09	−5.9%
Boston ScientificBSX	Open-market sale10b5-1 plan	25/01/03	25/01/03	9,689 sh	$89.86	$870,653.54	−4.1%
Boston ScientificBSX	Open-market sale10b5-1 plan	24/05/22–24/05/23	24/05/23	112,075 sh2 trades	$75.57avg.	$8,469,516.45	−33.4%
Boston ScientificBSX	Open-market sale	24/02/20	24/02/20	13,662 sh	$65.86	$899,779.32	−4.8%
Boston ScientificBSX	Open-market sale	23/03/01–23/03/02	23/03/02	105,610 sh2 trades	$46.65avg.	$4,926,250.4	−31.9%
Boston ScientificBSX	Open-market sale	23/02/15	23/02/16	7,572 sh	$47.14	$356,944.08	−2.7%